COVID-19 pandemic may signal the end of egalitarian National Health Service

COVID-19 pandemic may signal the end of egalitarian National Health Service

Dr Sabrina Germain, a Senior Lecturer in The City Law School, says the COVID-19 pandemic could signal the end of the National Health Service based on the liberal egalitarian conception of distributive justice. In her paper, "Will COVID-19 Mark the End of an Egalitarian National Health Service?", published in the European Journal of Risk Regulation, Dr Germain considers, first of all, why the allocation of healthcare resources is fundamentally a question of justice in Britain and explains why healthcare law and policy require a philosophical approach in times of crucial change and crisis. Secondly, the paper provides a critical analysis of the current situation for the allocation of healthcare resources and the provision of services to patients directly or indirectly affected by the virus. The paper concludes that the liberal egalitarian conception of distributive justice at the heart of the NHS, aiming to guarantee free and equal access to healthcare, is now in jeopardy and is being replaced by a utilitarian approach based on a priority ranking of patients for the provision of services at this critical time. Dr Germain argues that long before the advent of the COVID-19 pandemic, the resources available and mobilised for healthcare delivery in the UK have not matched the growing needs of society. Dr Germain's research has put a spotlight on the difficulties faced by governments such as the UK, in allocating scarce resources and services funded by taxpayers: Even though the NHS remains publicly funded, the provision of services is now ranking the needs of patients that are directly or indirectly affected by the virus rather than providing equal access to treatment for all. Going back to the egalitarian model that was already under strain prior to the advent of COVID-19 will be practicably impossible, even if current utilitarian emergency policies are suspended." Dr Sabrina Germain, Senior Lecturer, The City Law School Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More